Lingrui Pharma: Director Chen Yan plans to reduce holdings by no more than 200,000 shares

Lingrui Pharma announced on September 15th that the company's director Chen Yan plans to reduce his holdings of the company's shares by no more than 200,000 shares, or no more than 0.0353% of the company's total share capital, through centralized bidding trading within three months after 15 trading days from the date of the announcement due to personal funding needs. The reduction price will be determined based on the market price at the time of the reduction